Isosceles Pharmaceuticals, Inc.
UnclaimedMedicinal and Botanical ManufacturingWilmington, NC
Founded
2019
Primary NAICS
325411
CAGE code
8SBN8
Federal awards
—
Overview
Isosceles Pharmaceuticals is developing IPI201, a synthetic small-molecule immunotherapy adjuvant designed to convert immunologically cold tumors into checkpoint-sensitive targets.
Classification
This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Medicinal and Botanical Manufacturing325411
Capabilities
Water and Sewer Line and Related Structures ConstructionPharmaceutical Preparation ManufacturingChemical and Pharmaceutical Products Manufacturing MachineryHealth R&D Services; Health Care Services; Applied ResearchHealth R&D Services; Health Care Services; Experimental DevelopmentHealth R&D Services; Health Research and Training; Basic ResearchPharmacy Services